Gene · 25942
Papers3,655
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,655
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| How AlphaFold2 Predicts Conditionally Folding Regions Annotated in an Intrinsically Disordered Protein Database, IDEAL. | Biology (Basel) | 2023 | 36829461 | PubTator, text mining | PubMed |
| DDX47, MeCP2, and other functionally heterogeneous factors protect cells from harmful R loops. | Cell Rep | 2023 | 36827184 | PubTator, text mining | PubMed |
| Cell-specific expression of the FAP gene is regulated by enhancer elements. | Front Mol Biosci | 2023 | 36825204 | PubTator, text mining | PubMed |
| Genetic manipulation and targeted protein degradation in mammalian systems: practical considerations, tips and tricks for discovery research. | FEBS Open Bio | 2023 | 36815235 | PubTator, text mining | PubMed |
| Systematic analysis identifies REST as an oncogenic and immunological biomarker in glioma. | Sci Rep | 2023 | 36810892 | PubTator, text mining | PubMed |
| Can biomarkers identified from the uterine fluid transcriptome be used to establish a noninvasive endometrial receptivity prediction tool? A proof-of-concept study. | Reprod Biol Endocrinol | 2023 | 36805767 | PubTator, text mining | PubMed |
| Proximity labeling reveals a new in vivo network of interactors for the histone demethylase KDM5. | Epigenetics Chromatin | 2023 | 36803422 | PubTator, text mining | PubMed |
| Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies. | Signal Transduct Target Ther | 2023 | 36797244 | PubTator, text mining | PubMed |
| Skeletal muscle and intermuscular adipose tissue gene expression profiling identifies new biomarkers with prognostic significance for insulin resistance progression and intervention response. | Diabetologia | 2023 | 36790478 | PubTator, text mining | PubMed |
| Whole-genome functional characterization of RE1 silencers using a modified massively parallel reporter assay. | Cell Genom | 2023 | 36777181 | PubTator, text mining | PubMed |
| BRG1: Promoter or Suppressor of Cancer? The Outcome of BRG1's Interaction with Specific Cellular Pathways. | Int J Mol Sci | 2023 | 36769189 | PubTator, text mining | PubMed |
| The Regulation of Cyclins and Cyclin-Dependent Kinases in the Development of Gastric Cancer. | Int J Mol Sci | 2023 | 36769170 | PubTator, text mining | PubMed |
| A Mixture of Chemicals Found in Human Amniotic Fluid Disrupts Brain Gene Expression and Behavior in Xenopus laevis. | Int J Mol Sci | 2023 | 36768911 | PubTator, text mining | PubMed |
| Interaction between Long Noncoding RNAs and Syncytin-1/Syncytin-2 Genes and Transcripts: How Noncoding RNAs May Affect Pregnancy in Patients with Systemic Lupus Erythematosus. | Int J Mol Sci | 2023 | 36768581 | PubTator, text mining | PubMed |
| Epigenetic Perspective of Immunotherapy for Cancers. | Cells | 2023 | 36766706 | PubTator, text mining | PubMed |
| Krüppel-like factors in tumors: Key regulators and therapeutic avenues. | Front Oncol | 2023 | 36761967 | PubTator, text mining | PubMed |
| ZBTB12 is a molecular barrier to dedifferentiation in human pluripotent stem cells. | Nat Commun | 2023 | 36759523 | PubTator, text mining | PubMed |
| SIN3A Defects Associated with Syndromic Congenital Hypogonadotropic Hypogonadism: An Overlap with Witteveen-Kolk Syndrome. | Neuroendocrinology | 2023 | 36758531 | PubTator, text mining | PubMed |
| Retinal determination gene networks: from biological functions to therapeutic strategies. | Biomark Res | 2023 | 36750914 | PubTator, text mining | PubMed |
| SIN3A/HDAC complex subunit FAM60A is associated with the proliferation in colorectal cancer. | Asian J Surg | 2023 | 36737322 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/25942/papers?page=19